Request Demo
Last update 20 Mar 2025
Anti-CD19/CD22 CAR-T cell therapy (Chongqing Precision Biotech)
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms AntiCD19/AntiCD22 CART cell therapyChongqing Precision Biotech, CD19/CD22 dual CART Chongqing Precision Biotech |
Target |
Action inhibitors |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD22 inhibitors(CD22 inhibitors), Gene transference + [1] |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with Anti-CD19/CD22 CAR-T cell therapy (Chongqing Precision Biotech)NCT04782193
Study Evaluating Safety and Efficacy of CD19 and CD22 Targeted Prime CAR-T Cell in Patients With Relapsed/Refractory B Cell Lymphoma
NCT04781634
Study Evaluating Safety and Efficacy of CD19 and CD22 Targeted Prime CAR-T Cell in Patients with Relapsed/Refractory B-ALL
NCT04648475
CD19 and CD22 Targeted CAR-T Cell Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma
100 Clinical Results associated with Anti-CD19/CD22 CAR-T cell therapy (Chongqing Precision Biotech)
Login to view more data
100 Translational Medicine associated with Anti-CD19/CD22 CAR-T cell therapy (Chongqing Precision Biotech)
Login to view more data
100 Patents (Medical) associated with Anti-CD19/CD22 CAR-T cell therapy (Chongqing Precision Biotech)
Login to view more data
100 Deals associated with Anti-CD19/CD22 CAR-T cell therapy (Chongqing Precision Biotech)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pre B-cell acute lymphoblastic leukemia | Phase 2 | China | 07 Mar 2021 | |
| B-Cell Leukemia | Phase 2 | China | 01 Sep 2019 | |
| B-Cell Lymphoma | Phase 2 | China | 01 Sep 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free